Dr Reddy's Launches Hair Loss Tablets ‘Finasteride’ in US

Indian drug maker, Dr Reddy's Laboratories has launched its generic Finasteride tablets for treating male pattern hair loss in the American market.

The company has launched Finasteride tablets in the strength of 1 mg in the US market on January 2, 2013 following the approval of its abbreviated new drug application (ANDA) with 180 days of marketing exclusivity.

The tablets are bioequivalent generic version of Merck Sharp & Dohme Corp, a subsidiary of Merck & Co Inc's Propecia tablets.

The generic Finasteride tablets 1 mg of the company is available in bottle counts of 30 and 90.